Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension

Full text
Author(s):
Belo, Vanessa de Almeida ; Parente, Juliana Montenegro ; Tanus-Santos, Jose Eduardo ; Castro, Michele M.
Total Authors: 4
Document type: Journal article
Source: Biochemical Pharmacology; v. 118, p. 50-58, OCT 15 2016.
Web of Science Citations: 7
Abstract

Increased matrix metalloproteinase (MMP)-2 is implicated in the vascular remodeling of hypertension. Calponin-1 is a contractile protein, and its absence is associated with vascular smooth muscle cell (VSMC) phenotype switch, which leads to migration and remodeling. We evaluated whether increased MMP-2 activity precedes chronic vascular remodeling by decreasing calponin-1 and inducing VSMC proliferation. Sham or two kidney-one clip (2K1C) rats were treated with doxycycline at 30 mg/kg/day. Systolic blood pressure was increased in the 2K1C rats after 1 and 2 weeks post-surgery, and doxycycline was effective to reduce it only at 2 weeks of hypertension (p < 0.05). Increased activity of MMP-2 was observed in aortas from 2K1C at 1 and 2 weeks of hypertension, followed by increased VSMC proliferation, and those effects were abolished by treating 2K1C rats with doxycycline (p < 0.05). Increased aortic media to lumen ratio started to emerge in 2K1C rats at 1 week of hypertension, and it was established by 2 weeks. MMP-2 and calponin-1 co-localized in the cytosol of VSMC. Aortas from 2K1C rats showed a significant reduction in calponin-1 levels at 1 week of hypertension, and doxycycline prevented its loss (p < 0.05). However, at 2 weeks of hypertension, calponin-1 was upregulated in 2K1C (p < 0.05 vs. Sham groups). The mRNA levels of calponin-1 were not altered in the aortas of 2K1C at 1 week of hypertension. MMP-2 may contribute to the post-translational decrease in calponin-1, thus culminating in hypertension-induced maladaptive arterial remodeling. (C) 2016 Elsevier Inc. All rights reserved. (AU)

FAPESP's process: 14/11412-0 - Intracellular effect of matrix metalloproteinase (MMP)-2 in hypertension-mediated cardiovascular dysfunction
Grantee:Michele Mazzaron de Castro
Support Opportunities: Regular Research Grants